Epogen/Procrit
First Epoetin alfa Biosimilar Receives FDA Approval for Anemia
Retacrit is the first U.S. biosimilar erythropoiesis-stimulating agent (ESA). Although not listed as an ...
MAY 15, 2018
FDA Advisory Committee Recommends Approval for New Biosimilar of Epogen/Procrit
ODAC has recommended that Pfizer’s epoetin alfa biosimilar be approved across all indications. This marks the ...
MAY 26, 2017
Load more